Masimo Corp (MASI) CEO and Chairman of the Board Joe E Kiani Sold $17.8 million of Shares

Author's Avatar
GuruFocus News
01/11/2021 18:15
Article's Main Image

CEO and Chairman of the Board of Masimo Corp (30-Year Financial, Insider Trades) Joe E Kiani (insider trades) sold 63,274 shares of MASI on 01/11/2021 at an average price of $281.67 a share. The total sale was $17.8 million.

Masimo Corp is a medical technology company. The company develops, manufactures, and markets noninvasive monitoring technologies. Its product includes noninvasive blood constituent and brain and breath monitoring. Masimo Corp has a market cap of $15.41 billion; its shares were traded at around $279.920000 with a P/E ratio of 72.71 and P/S ratio of 14.54. Masimo Corp had annual average EBITDA growth of 14.10% over the past ten years. GuruFocus rated Masimo Corp the business predictability rank of 3.5-star. GuruFocus has detected 1 severe warning sign with Masimo Corp. .

CEO Recent Trades:

  • CEO and Chairman of the Board Joe E Kiani sold 63,274 shares of MASI stock on 01/11/2021 at the average price of $281.67. The price of the stock has decreased by 0.62% since.

Directors and Officers Recent Trades:

  • Pres-WW OEM & Global Health Jon Coleman sold 8,250 shares of MASI stock on 12/28/2020 at the average price of $264.02. The price of the stock has increased by 6.02% since.
  • EVP, Ops & Clinical Research Anand Sampath sold 30,000 shares of MASI stock on 12/15/2020 at the average price of $265.59. The price of the stock has increased by 5.4% since.

For the complete insider trading history of MASI, click here

.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].